These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2576771)

  • 1. The cellular immune response to the human immunodeficiency virus.
    Rivière Y
    Curr Opin Immunol; 1989-1990 Feb; 2(3):424-7. PubMed ID: 2576771
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune response to human immunodeficiency virus in homosexual men.
    Ranki A
    J Infect Dis; 1993 Feb; 167(2):498. PubMed ID: 8421190
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 5. Can immune responses to human immunodeficiency virus be preserved, enhanced, or restored?
    Walker BD
    AIDS Clin Rev; 2000-2001; ():101-14. PubMed ID: 10999218
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.
    Krohn K; Robey WG; Putney S; Arthur L; Nara P; Fischinger P; Gallo RC; Wong-Staal F; Ranki A
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4994-8. PubMed ID: 2440037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can immune systems be trained to fight HIV?
    Balter M
    Science; 1999 Nov; 286(5444):1470-11. PubMed ID: 10610544
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunology of HIV infection.
    Lewis DE; Giorgi JV
    Int Rev Immunol; 1990; 7(1):1-13. PubMed ID: 1983450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of HIV and CMV specific T-lymphocytes.
    Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F
    J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins.
    Mills KH; Nixon DF; McMichael AJ
    AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396
    [No Abstract]   [Full Text] [Related]  

  • 11. Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.
    Rivière Y
    Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():45-8. PubMed ID: 7950861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunopathogenesis of HIV infection.
    Rosenberg ZF; Fauci AS
    Adv Immunol; 1989; 47():377-431. PubMed ID: 2573256
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance of HIV-infected cells to cytotoxic T lymphocytes.
    Collins KL
    Microbes Infect; 2004 Apr; 6(5):494-500. PubMed ID: 15109965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from HIV infection or AIDS?
    Miedema F; Meyaard L; Klein MR
    Science; 1993 Nov; 262(5136):1074-6. PubMed ID: 8235627
    [No Abstract]   [Full Text] [Related]  

  • 15. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
    Klarnet JP; Kern DE; Okuno K; Holt C; Lilly F; Greenberg PD
    J Exp Med; 1989 Feb; 169(2):457-67. PubMed ID: 2562982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the immune response against hepatitis B virus by the human immunodeficiency virus.
    Hess G; Rossol S; Voth R; Weber KC; Meyer zum Büschenfelde KH
    Rheumatol Int; 1989; 9(3-5):175-9. PubMed ID: 2532781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD4 antigen: physiological ligand and HIV receptor.
    Sattentau QJ; Weiss RA
    Cell; 1988 Mar; 52(5):631-3. PubMed ID: 2830988
    [No Abstract]   [Full Text] [Related]  

  • 18. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.
    Blazevic V; Ranki A; Krohn KJ
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1335-42. PubMed ID: 8573390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic indices for the course of HIV infection].
    Hess G
    Verh Dtsch Ges Inn Med; 1991; 97():386-90. PubMed ID: 1687300
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals.
    Cosma A; Nagaraj R; Bühler S; Hinkula J; Busch DH; Sutter G; Goebel FD; Erfle V
    Vaccine; 2003 Dec; 22(1):21-9. PubMed ID: 14604567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.